June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Effect of Training Level on Outcomes of Phacoemulsification Combined with Kahook Dual Blade (KDB) Excisional Goniotomy
Author Affiliations & Notes
  • James Landreneau
    Ophthalmology, University of Missouri - Columbia, Columbia, Missouri, United States
  • Eli Pratte
    Ophthalmology, University of Missouri - Columbia, Columbia, Missouri, United States
  • Matthew Hirabayashi
    Ophthalmology, University of Missouri - Columbia, Columbia, Missouri, United States
  • Jella Angela An
    Ophthalmology, University of Missouri - Columbia, Columbia, Missouri, United States
    New World Medical, California, United States
  • Footnotes
    Commercial Relationships   James Landreneau, None; Eli Pratte, None; Matthew Hirabayashi, None; Jella An, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3153. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James Landreneau, Eli Pratte, Matthew Hirabayashi, Jella Angela An; Effect of Training Level on Outcomes of Phacoemulsification Combined with Kahook Dual Blade (KDB) Excisional Goniotomy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Kahook Dual Blade (KDB) goniotomy has proven effective in lowering intraocular pressure (IOP) and reducing the medication burden in patients with glaucoma. This study compares outcomes of a KDB goniotomy combined with phacoemulsification (phaco-KDB) between an ophthalmology attending and resident surgeons.

Methods : A retrospective analysis was performed on 96 eyes of 72 patients who received a phaco-KDB performed by either an ophthalmology attending or a senior ophthalmology resident under direct guidance of the attending. Data for each patient was collected preoperatively and at 1 week, 1 month, 3 months, 6 months, and 12 months postoperatively. The primary outcome measure was surgical success, defined as 20% IOP reduction or at least 1 medication reduction at each measured time point and incidence of any complications.

Results : Comparison of patient’s demographic information and glaucoma subtype/severity were not statistically significant between the resident’s and attending’s respective cohorts. Patient’s pre-operative mean IOP (p=0.938) and baseline glaucoma medications (p=0.164) were also comparable among the resident’s and attending’s study populations. At 6 months (63.5% in attending cohort vs. 87.5% in resident’s cohort) and 12 months (55.8% vs. 84.6%), primary surgeon was not significantly associated with outcome (P>0.05). Percent IOP reduction (5.8% vs. 18.1%) and medication reduction (1.2 vs. 0.7) did not differ between the groups at 6 or 12 months (P>0.05). Which surgeon performed the procedure did not significantly predict surgical complications (P=0.05). The survival distributions between the attending (mean 710.184±34.1 days) and resident (mean 724.5±29.8 days) were also not significantly different (χ2=2.013, P=.156).

Conclusions : Primary surgeon was not associated with outcome of phaco-KDB at any of the evaluated post-operative time points. The attending and residents had similar % IOP and medication reductions, complication rates, and survival distributions. This suggests phaco-KDB is an effective procedure with relatively short learning curve and can be safely performed by a trainee under direct supervision of experienced surgeon.

This is a 2020 ARVO Annual Meeting abstract.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×